Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLK1 | P53350 | 2/20 | 0.60 |
| ▸ | PLK2 | Q9NYY3 | 2/20 | 0.60 |
| ▸ | EEF2K | O00418 | 1/20 | 0.60 |
| ▸ | STAT3 | P40763 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 7/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | MEN1 | O00255 | 4/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.43 |
| ▸ | LMNA | P02545 | 4/20 | 0.43 |
| ▸ | BLM | P54132 | 3/20 | 0.43 |
| ▸ | GAA | P10253 | 3/20 | 0.43 |
| ▸ | USP2 | O75604 | 2/20 | 0.43 |
| ▸ | TP53 | P04637 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | HSPD1 | P10809 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | CDC25A | P30304 | 2/20 | 0.43 |
| ▸ | CDC25B | P30305 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14507718 | 0.87 | PLK1 (0.50) | PLK1PLK2EEF2KSTAT3MAPT | |
| SCHEMBL3624714 | 0.83 | ALDH1A1 (0.50) | PLK1PLK2EEF2KSTAT3MAPT | |
| SCHEMBL7946964 | 0.82 | PLK1 (0.46) | PLK1PLK2EEF2KSTAT3MAPT | |
| SCHEMBL11704367 | 0.82 | PLK1 (0.46) | PLK1PLK2EEF2KSTAT3MAPT | |
| SCHEMBL5162553 | 0.82 | EEF2K (0.46) | PLK1PLK2EEF2KSTAT3MAPT | |
| SCHEMBL754556 | 0.82 | EEF2K (0.46) | PLK1PLK2EEF2KSTAT3MAPT | |
| SCHEMBL2931396 | 0.82 | EEF2K (0.46) | PLK1PLK2EEF2KSTAT3MAPT | |
| SCHEMBL9655273 | 0.78 | STAT3 (0.61) | PLK1PLK2EEF2KSTAT3MAPT | |
| Coprinin SCHEMBL3416504 | 0.78 | ERBB2 (0.50) | PLK1PLK2EEF2KSTAT3MAPT | |
| SCHEMBL2552489 | 0.78 | MAPT (0.43) | PLK1PLK2EEF2KSTAT3MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 939 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4715006-A2 | UNSATURATED SCORCH RETARDERS | Nouryon Chemicals International B.V. (NL) | 2026-03-25 | — | — | EP | claimed |
| US-20260078088-A1 | UNSATURATED SCORCH RETARDERS | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2026-03-19 | — | — | US | claimed |
| WO-2025101956-A2 | CONTROL OF ENZYMATIC NUCLEIC ACID SYNTHESIS VIA ELECTROCHEMICAL MEANS | THE CHARLES STARK DRAPER LABORATORY, INC. (US) | 2025-05-15 | — | — | WO | claimed |
| CN-119977819-A | Organic electric energy transfer eutectic crystal with near infrared light thermal characteristics and preparation method of light heat storage fiber thereof | 苏州大学 | 2025-05-13 | — | — | CN | claimed |
| CN-119740772-A | Energy storage, site selection and volume determination optimization method and system | 国网山东省电力公司电力科学研究院 | 2025-04-01 | — | — | CN | claimed |
| CN-119419302-A | Lithium-fluorocarbon battery electrolyte containing redox medium and preparation method and application thereof | 中国科学院长春应用化学研究所 | 2025-02-11 | — | — | CN | claimed |
| EP-3892723-B1 | BILIRUBIN OXIDASE ACTIVITY IMPROVING METHOD, AND PRODUCT COMPRISING BILIRUBIN OXIDASE | OZEKI KK (JP) | 2025-01-22 | — | — | EP | claimed |
| US-20240280535-A1 | LOCAL SENSING AND CONTROL OF PH FOR PARALLELIZED SYNTHESIS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2024-08-22 | — | — | US | claimed |
| CN-118388460-A | 5- (1H-indole-1-yl) -dihydrofuran-2- (3H) -ketone compound and synthetic method thereof | 华南理工大学 | 2024-07-26 | — | — | CN | claimed |
| US-20240209423-A1 | METHODS AND COMPOSITIONS FOR REDUCING AUTOFLUORESCENCE | ADVANCED CELL DIAGNOSTICS, INC. | 2024-06-27 | — | — | US | claimed |
| WO-2003042199-A1 | AGENT AND METHOD FOR COLORING KERATIN FIBERS CONTAINING 2-BENZOTHIAZOLINONE-HYDRAZONE AND QUINONE DERIVATIVES | WELLA AKTIENGESELLSCHAFT (DE) | 2003-05-22 | — | — | WO | claimed |
| WO-2003033726-A1 | AMPEROMETRIC SENSOR | DREW SCIENTIFIC LIMITED (GB) | 2003-04-24 | — | — | WO | claimed |
| EP-0005140-B1 | NOVEL 4-DESOXY-THIAZOLO (5,4-C) RIFAMYCIN DERIVATIVES AND A PROCESS FOR PREPARING THEM | GRUPPO LEPETIT S.P.A. (IT) | 1982-10-27 | — | — | EP | claimed |
| US-4234485-A | REACTING RIFAMYCIN S, CYSTEINE OR CYSTEAMINE, AN OXIDIZER, AND A HYROXYAMINE, A HYDRAZINE, OR A HYDRAZIDE; ONE-STEP | GRUPPO LEPETIT S.P.A. (IT) | 1980-11-18 | — | — | US | claimed |
| US-4220528-A | CONTACTING A GAS WITH A SOLUTION CONTAINING A HYDRAZINE, A QUINONE, AN ALKALI; CONTACTING THE DEOXYGENATED GAS WITH WATER | OTSUKA CHEMICAL CO., LTD. (JP) | 1980-09-02 | — | — | US | claimed |
| US-4201588-A | NONSILVER PHOTOGRAPHIC FILMS; DISULFIDE, DIAZOANTHRONE, DIAZOPHENANTHRONE, AROMATIC AZIDE, CARBAZIDES OR QUINONES AS PHOTOREDUCTANT; EXTERNAL HYDROGEN SOURCE | EASTMAN KODAK COMPANY (US) | 1980-05-06 | — | — | US | claimed |
| US-4187205-A | Radiation-sensitive composition | NIPPON TELEGRAPH AND TELEPHONE PUBLIC CORPORATION (JP) | 1980-02-05 | — | — | US | claimed |
| EP-0005140-A2 | Novel 4-desoxy-thiazolo (5,4-c) rifamycin derivatives and a process for preparing them | GRUPPO LEPETIT S.P.A. (IT) | 1979-11-14 | — | — | EP | claimed |
| US-4144234-A | Preparation of rifamycin P and Q derivatives | GRUPPO LEPETIT S.P.A. (IT) | 1979-03-13 | — | — | US | claimed |
| US-4129562-A | ANTIBACTERIAL AGENTS WITH LOW TOXICITY | GRUPPO LEPETIT S.P.A. (IT) | 1978-12-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078088-A1 | UNSATURATED SCORCH RETARDERS | SCO2, OXER1, CBR1 | PLK1 3869/4885PLK2 2811/4885EEF2K 4319/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.